Emanuela Vattemi
Bolzano, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Corrigendum to 'Real-life management of stage III non-small cell lung cancer patients in Italy: the BE-PACIFIC observational study' [Cancer Treat Res Commun. 2026:47:101143].
Journal: Cancer treatment and research communications
Published: August 25, 2026
Chemoimmunotherapy Combinations in Elderly Patients with Metastatic Non-Small Cell Lung Cancer and PD-L1 Expression < 50%: Results from an Italian Real-World Study.
Journal: Journal of clinical medicine
Published: November 23, 2025
Real-life management of stage III non-small cell lung cancer patients in Italy: the BE-PACIFIC observational study.
Journal: Cancer treatment and research communications
Published: March 24, 2025
Real-world effectiveness and safety of first-line chemoimmunotherapy combinations in metastatic non-small cell lung cancer with programmed death ligand-1 < 50%: results from an Italian observational study.
Journal: Cancer immunology, immunotherapy : CII
Published: March 09, 2025
SCLC Treatment in the Immuno-Oncology Era: Current Evidence and Unmet Needs.
Journal: Frontiers in oncology
Published: December 21, 2021
Pretreatment lung immune prognostic index as a biomarker in advanced non-small-cell lung cancer patients receiving first line pembrolizumab.
Journal: Immunotherapy
Published: June 30, 2021
Be-TeaM: An Italian real-world observational study on second-line therapy for EGFR-mutated NSCLC patients.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: September 16, 2019
Oral maintenance metronomic vinorelbine versus best supportive care in advanced non-small-cell lung cancer after platinum-based chemotherapy: The MA.NI.LA. multicenter, randomized, controlled, phase II trial.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: December 17, 2018
A New Genetic Risk Score to Predict the Outcome of Locally Advanced or Metastatic Breast Cancer Patients Treated With First-Line Exemestane: Results From a Prospective Study.
Journal: Clinical breast cancer
Published: October 01, 2018
Impact of the IASLC/ATS/ERS classification in pN0 pulmonary adenocarcinomas: a study with radiological-pathological comparisons and survival analyses.
Journal: Pathology, research and practice
Published: July 23, 2013
Last Updated: 09/26/2026